Front Desk: 469-391-0070
Glatiramer Acetate: MS Treatment, Benefits, and Dosage Guide
Summary of Key Points
Glatiramer acetate is a prescription medication primarily used to treat multiple sclerosis (MS) and other autoimmune conditions that affect the nervous system. This medication helps reduce the frequency of relapses and slows the progression of the disease. It is administered as a subcutaneous injection. Always consult a healthcare provider before starting or adjusting your dosage. Our telemedicine providers are here to support you in managing your treatment effectively.
Names of the Medication
US Brand Name: Copaxone
Generic Name: Glatiramer acetate
The generic name, Glatiramer acetate, refers to the active ingredient in the medication, while the brand name, Copaxone, is the name given by the manufacturer.
Pharmacologic Category
Category: Immunomodulator
Other MS therapies in this category include interferon beta-1a (Avonex, Rebif), interferon beta-1b (Betaseron), and fingolimod (Gilenya). These disease-modifying therapies are designed to help manage symptoms and slow the progression of MS.
Dosing Guidelines
Glatiramer acetate is prescribed for multiple sclerosis and other autoimmune diseases that impact the nervous system. Below are the dosing guidelines for adults. Always consult your doctor before making any changes to your dosage. Our telemedicine providers are available to answer any questions you may have about Glatiramer acetate dosing and treatment plans.
Multiple Sclerosis (MS) and Relapsing Forms of MS
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week (with at least 48 hours between doses).
Length of Treatment: Long-term treatment is recommended to manage symptoms and reduce relapses.
Secondary Progressive Multiple Sclerosis (SPMS)
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment, as directed by your healthcare provider.
Primary Progressive Multiple Sclerosis (PPMS)
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment, depending on your response to the medication.
Neuromyelitis Optica (NMO)
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment to manage symptoms and prevent relapses.
Optic Neuritis
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: As directed by your healthcare provider.
Transverse Myelitis
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment may be needed to prevent relapses.
Acute Disseminated Encephalomyelitis (ADEM)
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Consult your healthcare provider for the appropriate treatment duration.
Autoimmune Encephalitis
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment may be required to manage symptoms.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Dosage: 20 mg injected under the skin once daily or 40 mg injected three times per week.
Length of Treatment: Long-term treatment may be necessary to control symptoms.
Dosage Forms and Strengths
Available Forms:
- Pre-filled syringes: 20 mg/mL
- Pre-filled syringes: 40 mg/mL
Administration Instructions
Glatiramer acetate is administered as a subcutaneous injection, meaning it is injected just beneath the skin. To minimize irritation or skin damage, it is essential to rotate injection sites. Common injection sites include the arms, thighs, hips, and abdomen. Be sure to follow the instructions provided by your healthcare provider or pharmacist carefully. If you have any questions about how to administer Glatiramer acetate, our telemedicine providers are available to guide you through the process.
Adverse Reactions and Side Effects
As with any medication, Glatiramer acetate may cause side effects. It’s important to be aware of these and to contact your healthcare provider if you experience any concerning symptoms. Below is a list of potential side effects, categorized by how frequently they occur:
Common Side Effects (affecting more than 1 in 10 patients)
Injection site reactions: Redness, pain, or swelling at the injection site.
Flushing: A sudden sensation of warmth and redness in the face or neck.
Less Common Side Effects (affecting 1 in 100 patients)
Chest pain: A feeling of tightness or discomfort in the chest, typically temporary.
Palpitations: A sensation of a rapid or irregular heartbeat.
Rare Side Effects (affecting fewer than 1 in 1,000 patients)
Severe allergic reactions: Symptoms may include difficulty breathing, swelling of the face or throat, and hives. Seek immediate medical attention if this occurs.
Liver issues: Signs may include unexplained fatigue, yellowing of the skin or eyes, or dark urine, which could indicate liver problems.
If you experience any side effects, contact your healthcare provider promptly. Our telemedicine providers are available to help address any concerns related to your treatment.
Contraindications
A contraindication refers to a specific condition or circumstance in which using a particular medication could be harmful. Glatiramer acetate, a commonly prescribed treatment for multiple sclerosis (MS), has certain contraindications that should be carefully reviewed before starting therapy. If any of the following apply to you, it’s important to consult your healthcare provider or schedule a telemedicine appointment to determine whether Glatiramer acetate is a safe and appropriate option for your condition.
Contraindications for Glatiramer Acetate
Allergy to Glatiramer Acetate or Mannitol: If you have a known allergy to Glatiramer acetate or mannitol (an inactive ingredient in the medication), this treatment should be avoided. Allergic reactions can range from mild symptoms, such as skin rash or itching, to more severe reactions, including difficulty breathing or swelling of the face, lips, or throat. If you suspect an allergic reaction, seek medical attention immediately.
Severe Heart Disease: Individuals with significant heart conditions may experience worsening symptoms, such as chest pain or irregular heartbeats, after taking Glatiramer acetate. This is due to potential short-term reactions that can place additional strain on the cardiovascular system. Be sure to discuss your heart health with your provider before starting this medication.
Severe Kidney Disease: Patients with advanced kidney impairment may have difficulty metabolizing Glatiramer acetate, which could increase the risk of complications. If you have kidney disease, it’s essential to inform your healthcare provider so they can assess whether this treatment is suitable for you.
Drug-to-Drug Interactions
Drug interactions occur when one medication affects the efficacy or side effects of another. While Glatiramer acetate is generally compatible with many medications, certain interactions should be considered to minimize potential risks.
Medications That May Interact with Glatiramer Acetate
Immunosuppressants: Medications such as azathioprine (Imuran) or methotrexate can increase the risk of infections when used alongside Glatiramer acetate, as both suppress the immune system. If you are taking immunosuppressants, your provider may need to adjust your treatment plan or monitor you more closely.
Corticosteroids: Drugs like prednisone (Deltasone) or methylprednisolone (Medrol) may amplify the likelihood of side effects, particularly when used long-term in combination with Glatiramer acetate. Discuss the duration and dosage of corticosteroid use with your healthcare provider to ensure safe treatment.
Live Vaccines: Vaccines such as MMR (measles, mumps, rubella) or varicella (chickenpox) may be less effective when administered alongside Glatiramer acetate. Additionally, there may be an increased risk of developing an infection from the vaccine itself. Inform your provider about any upcoming vaccinations so they can guide you on the best timing and approach.
Glatiramer Acetate in Pregnancy
Is Glatiramer acetate safe during pregnancy?
There is limited research on the safety of Glatiramer acetate during pregnancy. While animal studies have not shown harm to the fetus, data from human studies remain insufficient. If you are pregnant or planning to become pregnant, it’s crucial to weigh the potential benefits and risks with your healthcare provider. For some women with multiple sclerosis, continuing Glatiramer acetate during pregnancy may be recommended if the benefits outweigh the risks. This decision should always be made in close consultation with your provider. Consider scheduling a telemedicine appointment to discuss your options for managing MS during pregnancy.
Glatiramer Acetate While Breastfeeding
Is Glatiramer acetate safe while breastfeeding?
There is limited information on whether Glatiramer acetate passes into breast milk. However, due to its large molecular structure, it is unlikely to be absorbed by the nursing infant. Many healthcare providers consider Glatiramer acetate safe for use during breastfeeding, but it’s essential to discuss your individual circumstances with your provider. If you are breastfeeding or planning to breastfeed, schedule a consultation to determine whether this disease-modifying therapy is appropriate for you.
Estimated Cost of Glatiramer Acetate
The cost of Glatiramer acetate can vary widely depending on the pharmacy and your insurance coverage. Without insurance, a 30-day supply typically costs between $5,000 and $6,000 when using a GoodRX coupon. To get an accurate estimate, check with your pharmacy and explore financial assistance programs if needed. If you’re considering Glatiramer acetate as part of your MS treatment plan, ask your provider about cost-saving options, including generic alternatives like Copaxone, which may be more affordable.
Possible Alternatives to Glatiramer Acetate
There are several alternative treatments and lifestyle adjustments to consider for conditions typically managed with Glatiramer acetate. It’s important to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine appointment with one of our providers to discuss these options in greater detail.
Multiple Sclerosis (MS) and Relapsing Forms of MS
Alternative Medications: Other disease-modifying therapies (DMTs) for MS include interferon beta-1a (Avonex, Rebif), interferon beta-1b (Betaseron), and dimethyl fumarate (Tecfidera). These medications work through different mechanisms than Glatiramer acetate but are also effective in managing relapsing forms of MS.
Lifestyle Changes: Incorporating regular exercise, maintaining a balanced diet, and practicing stress management techniques can help alleviate MS symptoms and enhance overall well-being. These lifestyle adjustments complement medical treatments and may amplify their benefits.
Secondary Progressive MS
Alternative Medications: Siponimod (Mayzent) and cladribine (Mavenclad) are potential options for managing secondary progressive MS. These medications may be considered if Glatiramer acetate or other therapies are not suitable for your condition.
Lifestyle Changes: Physical therapy and staying active are key strategies for managing symptoms and slowing disease progression. These approaches are vital for improving mobility and maintaining quality of life.
Primary Progressive MS
Alternative Medications: Ocrelizumab (Ocrevus) is currently the only FDA-approved treatment for primary progressive MS. While Glatiramer acetate is not indicated for this form of MS, Ocrelizumab provides a targeted approach to managing the condition.
Lifestyle Changes: Engaging in regular physical activity, following a nutritious diet, and managing stress can help improve overall quality of life. These changes work in tandem with medical treatments to support your health.
Neuromyelitis Optica (NMO)
Alternative Medications: Eculizumab (Soliris) and inebilizumab (Uplizna) are FDA-approved treatments for NMO. These therapies target specific immune pathways involved in the disease, offering effective alternatives to Glatiramer acetate for NMO management.
Lifestyle Changes: Managing stress and ensuring adequate rest may help reduce the frequency of relapses. These lifestyle adjustments provide valuable support alongside medical treatments.
Optic Neuritis
Alternative Medications: High-dose corticosteroids, such as methylprednisolone (Solu-Medrol), are commonly used to treat optic neuritis. While Glatiramer acetate is not indicated for this condition, corticosteroids can help reduce inflammation and accelerate recovery.
Lifestyle Changes: Avoiding smoking and maintaining a healthy diet can promote eye health and potentially lower the risk of future episodes. These changes are simple yet impactful steps toward long-term well-being.
Transverse Myelitis
Alternative Medications: Corticosteroids and plasma exchange therapy are often used to treat transverse myelitis. These treatments address inflammation and modulate immune system activity, offering effective alternatives to Glatiramer acetate for this condition.
Lifestyle Changes: Physical therapy and rehabilitation play a crucial role in improving mobility and functionality. These interventions are essential for recovery and long-term management.
Acute Disseminated Encephalomyelitis (ADEM)
Alternative Medications: High-dose corticosteroids are typically the first line of treatment for ADEM. These medications help reduce inflammation and support recovery, providing a different therapeutic approach than Glatiramer acetate.
Lifestyle Changes: Rest and rehabilitation therapy are key components of recovery following an ADEM episode. These strategies help restore strength and functionality over time.
Autoimmune Encephalitis
Alternative Medications: Immunosuppressive therapies, such as rituximab (Rituxan) or cyclophosphamide (Cytoxan), are often used to manage autoimmune encephalitis. These treatments target the immune system, offering viable alternatives to Glatiramer acetate for this condition.
Lifestyle Changes: Cognitive rehabilitation and supportive therapies can help address long-term symptoms. These interventions are critical for enhancing quality of life and promoting recovery.
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Alternative Medications: Intravenous immunoglobulin (IVIG) and corticosteroids are commonly prescribed for CIDP. These therapies provide effective options beyond Glatiramer acetate for managing this condition.
Lifestyle Changes: Physical therapy and maintaining an active lifestyle are essential for managing symptoms. These approaches help preserve mobility and independence, contributing to a better quality of life.
Recent Updates on Glatiramer Acetate Research
Recent studies continue to affirm the long-term safety and effectiveness of Glatiramer acetate in managing relapsing forms of multiple sclerosis. Research indicates that patients treated with Glatiramer acetate experience fewer relapses and slower progression of disability compared to those not receiving treatment. Additionally, ongoing studies are investigating the potential benefits of Glatiramer acetate in other autoimmune conditions, such as neuromyelitis optica and chronic inflammatory demyelinating polyneuropathy. While these studies are still in their early stages, they offer promising insights into expanding the use of this medication in the future.
